Risperidone for non-psychotic disorders in paediatric patients: which child is to benefit?

Pieter J. Hoekstra*

*Corresponding author for this work

    Research output: Contribution to journalEditorialAcademicpeer-review

    5 Citations (Scopus)

    Abstract

    This commentary is on the original article by Youngster etal. on pages of this issue.

    Original languageEnglish
    Pages (from-to)919-920
    Number of pages2
    JournalDevelopmental Medicine and Child Neurology
    Volume56
    Issue number10
    DOIs
    Publication statusPublished - Oct-2014

    Keywords

    • INDUCED WEIGHT-GAIN
    • ADOLESCENTS
    • AUTISM
    • ANTIPSYCHOTICS
    • GENE

    Fingerprint

    Dive into the research topics of 'Risperidone for non-psychotic disorders in paediatric patients: which child is to benefit?'. Together they form a unique fingerprint.

    Cite this